Chronic myelomonocytic leukemia: A rare hematologic malignancy that needs due consideration

<p>Chronic Myelomonocytic Leukemia (CMML) is a malignant hematopoietic stem cell disorder with clinical and pathological features of both a myeloproliferative neoplasm and myelodysplastic syndrome [1]. According to the 2016 WHO classification of hematologic malignancies it is categorized as My...

Full description

Saved in:
Bibliographic Details
Main Authors: Temesgen Assefa (Author), Yosef Alebel (Author)
Format: Book
Published: Archives of Hematology Case Reports and Reviews - Peertechz Publications, 2020-11-07.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_ahcrr_000026
042 |a dc 
100 1 0 |a Temesgen Assefa  |e author 
700 1 0 |a Yosef Alebel  |e author 
245 0 0 |a Chronic myelomonocytic leukemia: A rare hematologic malignancy that needs due consideration 
260 |b Archives of Hematology Case Reports and Reviews - Peertechz Publications,   |c 2020-11-07. 
520 |a <p>Chronic Myelomonocytic Leukemia (CMML) is a malignant hematopoietic stem cell disorder with clinical and pathological features of both a myeloproliferative neoplasm and myelodysplastic syndrome [1]. According to the 2016 WHO classification of hematologic malignancies it is categorized as MyeloDysplastic /Myeloproliferative Neoplasm [2].</p> 
540 |a Copyright © Temesgen Assefa et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/ahcrr.000026  |z Connect to this object online.